I C van Eijk

863 total citations
13 papers, 614 citations indexed

About

I C van Eijk is a scholar working on Rheumatology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, I C van Eijk has authored 13 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 4 papers in Hematology. Recurrent topics in I C van Eijk's work include Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Lupus Erythematosus Research (5 papers). I C van Eijk is often cited by papers focused on Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Lupus Erythematosus Research (5 papers). I C van Eijk collaborates with scholars based in Netherlands, United States and Poland. I C van Eijk's co-authors include Michael T. Nurmohamed, Yvo M. Smulders, Ben A. C. Dijkmans, Erik H. Serné, Irene E. van der Horst‐Bruinsma, Mike J. Peters, Irene van der Horst‐Bruinsma, Gertjan Wolbink, Mirjam K. de Vries and Bouke P. C. Hazenberg and has published in prestigious journals such as Annals of the Rheumatic Diseases, Medicine and Lara D. Veeken.

In The Last Decade

I C van Eijk

13 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I C van Eijk Netherlands	12	483	179	162	102	65	13	614
Jean‐Frédéric Boyer France	10	323 0.7×	181 1.0×	109 0.7×	54 0.5×	40 0.6×	15	553
Lena Innala Sweden	7	520 1.1×	105 0.6×	74 0.5×	77 0.8×	34 0.5×	11	630
Suzanne P. Linn-Rasker Netherlands	9	748 1.5×	139 0.8×	59 0.4×	132 1.3×	47 0.7×	14	979
Stephen Jarrett United Kingdom	9	409 0.8×	86 0.5×	89 0.5×	138 1.4×	104 1.6×	9	575
Larissa Lisnevskaia Canada	6	505 1.0×	394 2.2×	111 0.7×	47 0.5×	35 0.5×	8	738
Matt Cravets United States	11	330 0.7×	106 0.6×	135 0.8×	157 1.5×	50 0.8×	17	679
Koji Tsugawa Japan	16	166 0.3×	153 0.9×	150 0.9×	43 0.4×	82 1.3×	51	564
P. Vlachoyiannopoulos Greece	13	260 0.5×	151 0.8×	67 0.4×	45 0.4×	70 1.1×	17	503
Takeshi Nakatsue Japan	13	168 0.3×	92 0.5×	171 1.1×	33 0.3×	45 0.7×	42	593
Saverio Alvaro Italy	9	169 0.3×	119 0.7×	170 1.0×	60 0.6×	34 0.5×	11	548

Countries citing papers authored by I C van Eijk

Since Specialization

Citations

This map shows the geographic impact of I C van Eijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I C van Eijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I C van Eijk more than expected).

Fields of papers citing papers by I C van Eijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I C van Eijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I C van Eijk. The network helps show where I C van Eijk may publish in the future.

Co-authorship network of co-authors of I C van Eijk

This figure shows the co-authorship network connecting the top 25 collaborators of I C van Eijk. A scholar is included among the top collaborators of I C van Eijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I C van Eijk. I C van Eijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Oever, Inge A. M. van den, Suat Şimşek, Hennie G. Raterman, et al.. (2020). The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis. Rheumatology International. 41(2). 319–328. 24 indexed citations

Houben, Eline, Willem A. Bax, Bastiaan van Dam, et al.. (2016). Diagnosing ANCA-associated vasculitis in ANCA positive patients. Medicine. 95(40). e5096–e5096. 52 indexed citations

Sijl, Alper M. van, I C van Eijk, Mike J. Peters, et al.. (2013). Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 74(1). 119–123. 52 indexed citations

Sijl, Alper M. van, I C van Eijk, Matthew Peters, et al.. (2013). FRI0427 Tumor necrosis factor blocking agents inhibit the progression of preclinical atherosclerosis in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 72. A519–A519. 3 indexed citations

Eijk, I C van, M. Nielen, Irene van der Horst‐Bruinsma, et al.. (2011). Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial. Lara D. Veeken. 51(4). 686–694. 40 indexed citations

Eijk, I C van, Erik H. Serné, Ben A. C. Dijkmans, Yvo M. Smulders, & Michael T. Nurmohamed. (2011). Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity. Clinical Rheumatology. 30(8). 1113–1118. 17 indexed citations

Eijk, I C van, Maarten E. Tushuizen, Augueste Sturk, et al.. (2009). Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. Annals of the Rheumatic Diseases. 69(7). 1378–1382. 32 indexed citations

Peters, Mike J., I C van Eijk, Yvo M. Smulders, et al.. (2009). Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis. The Journal of Rheumatology. 37(1). 161–166. 83 indexed citations

Eijk, I C van, Mirjam K. de Vries, J.H.M. Levels, et al.. (2009). Improvement of lipid profile is accompanied by atheroprotective alterations in high‐density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis. Arthritis & Rheumatism. 60(5). 1324–1330. 82 indexed citations

10.

Vries, Mirjam K. de, I C van Eijk, Irene van der Horst‐Bruinsma, et al.. (2009). Erythrocyte sedimentation rate, C‐reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti–tumor necrosis factor treatment in ankylosing spondylitis. Arthritis Care & Research. 61(11). 1484–1490. 98 indexed citations

11.

Raterman, Hennie G., I C van Eijk, Alexandre E. Voskuyl, et al.. (2008). The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study. Annals of the Rheumatic Diseases. 69(1). 39–42. 24 indexed citations

12.

Eijk, I C van, M.J. Peters, Erik H. Serné, et al.. (2008). Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor α blockade. Annals of the Rheumatic Diseases. 68(3). 362–366. 93 indexed citations

13.

Eijk, I C van, Matthew Peters, Michael T. Nurmohamed, et al.. (2007). Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis. European Journal of Endocrinology. 156(3). 291–293. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact